Explore
Validate
LearnMAB3479
antibody from R&D Systems
Targeting: FPR2
ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB3479 - Provider product page
- Provider
- R&D Systems
- Product name
- Human FPRL1/FPR2 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Stains FPRL1 transfectants but not irrelevant transfectants. It also stains monocytes and granulocytes.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
P25090- Isotype
- IgG
- Antibody clone number
- 304405
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Annexin A1, FPR2/ALX, and inflammatory cytokine expression in peritoneal endometriosis.
Intracellular formyl peptide receptor regulates naïve CD4 T cell migration.
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.
Volpato LK, Horewicz VV, Bobinski F, Martins DF, Piovezan AP
Journal of reproductive immunology 2018 Sep;129:30-35
Journal of reproductive immunology 2018 Sep;129:30-35
Intracellular formyl peptide receptor regulates naïve CD4 T cell migration.
Lee HY, Jeong YS, Lee M, Kweon HS, Huh YH, Park JS, Hwang JE, Kim K, Bae YS
Biochemical and biophysical research communications 2018 Feb 26;497(1):226-232
Biochemical and biophysical research communications 2018 Feb 26;497(1):226-232
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.
Prevete N, Liotti F, Visciano C, Marone G, Melillo RM, de Paulis A
Oncogene 2015 Jul;34(29):3826-38
Oncogene 2015 Jul;34(29):3826-38
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.
Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, Pande R, Creager MA, Serhan CN, Conte MS
The American journal of pathology 2010 Oct;177(4):2116-23
The American journal of pathology 2010 Oct;177(4):2116-23
No comments: Submit comment
Supportive validation
- Submitted by
- R&D Systems (provider)
- Main image
- Experimental details
- Detection of FPRL1/FPR2 in Human Blood Monocytes by Flow Cytometry. Human peripheral blood monocytes were stained with Mouse Anti-Human FPRL1/ FPR2 Monoclonal Antibody (Catalog # MAB3479, filled histogram) or isotype control antibody (Catalog # MAB004, open histogram), followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0101B). View our protocol for Staining Membrane-associated Proteins.
